What is the price target for USNA stock?
6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 129.41% is expected in the next year compared to the current price of 17.34.
USANA HEALTH SCIENCES INC (USNA) Forecast, Price Target & Analyst Ratings
NYSE:USNA • US90328M1071
Current stock price
17.34 USD
+0.13 (+0.76%)
At close:
17.34 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for USANA HEALTH SCIENCES INC (USNA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 20, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.45
- Revenue Estimate
- 245.76M
Price Target Details & History
Consensus Price Target and Range
Mean target
$39.78
Upside
+ 129.41%
From current price of $17.34 to mean target of $39.78, Based on 6 analyst forecasts
Low
$39.39
Median
$39.78
High
$40.95
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for USNA. The average price target is 39.78 USD. This implies a price increase of 129.41% is expected in the next year compared to the current price of 17.34.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
USNA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about USNA.
In the previous month the buy percentage consensus was at a similar level.
USNA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-02-27 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-01-02 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-10-23 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-07-25 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-05-07 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-02-22 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-10-25 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-04-26 | DA Davidson | Maintains | Neutral |
| 2023-02-13 | DA Davidson | Maintains | Neutral |
| 2022-10-27 | DA Davidson | Maintains | Neutral |
| 2022-07-28 | DA Davidson | Maintains | Neutral |
| 2022-07-12 | DA Davidson | Maintains | Neutral |
| 2022-07-07 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-04-27 | DA Davidson | Maintains | Neutral |
| 2022-04-14 | DA Davidson | Initiate | Neutral |
| 2021-02-10 | Roth Capital | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 20, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.45
- Revenue Estimate
- 245.76M
- Revenue Q2Q
- -1.51%
- EPS Q2Q
- -38.52%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
2.08%
EPS (1 Month)
0.00%
EPS (3 Months)
2.50%
Next Earnings Summary
USNA is expected to report earnings on 4/20/2026. The consensus EPS estimate for the next earnings is 0.45 USD and the consensus revenue estimate is 245.76M USD.
The next earnings revenue estimate has been revised upward by 2.08% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 921.01M -7.77% | 854.503M -7.22% | 925.257M 8.28% | 961.25M 3.89% | 1.021B 6.22% | |
| EBITDA YoY % growth | 105.773M -12.58% | 80.863M -23.55% | N/A 25.32% | 105.31M 3.92% | 128.27M 21.80% | |
| EBIT YoY % growth | 93.071M -13.50% | 66.324M -28.74% | 50.862M -23.31% | 52.035M 2.31% | 75.099M 44.32% | |
| Operating Margin | 10.11% | 7.76% | 5.50% | 5.41% | 7.36% | |
| EPS YoY % growth | 3.30 -8.08% | 2.60 -21.21% | 1.92 -26.15% | 2.04 6.25% | 2.83 38.50% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.45 -38.52% | 0.46 -37.97% | 0.51 440.00% | 0.57 -4.80% | 0.61 36.36% | 0.63 37.78% | 0.79 54.00% | 0.78 35.71% |
| Revenue Q2Q % growth | 245.76M -1.51% | 242.69M 2.83% | 231.26M 8.07% | 235.59M 4.15% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 22.894M -4.65% | 25.846M -21.20% | 27.735M 9.95% | 31.104M 20.46% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 9.638M -38.50% | 12.564M -24.85% | 17.544M 1,333.33% | 18.87M 9.40% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
USANA HEALTH SCIENCES INC / USNA Forecast FAQ
Can you provide the upcoming earnings date for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) will report earnings on 2026-04-20, after the market close.
Can you provide the consensus estimates for USANA HEALTH SCIENCES INC next earnings?
The consensus EPS estimate for the next earnings of USANA HEALTH SCIENCES INC (USNA) is 0.45 USD and the consensus revenue estimate is 245.76M USD.
What is the consensus rating for USNA stock?
The consensus rating for USANA HEALTH SCIENCES INC (USNA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.